Correlation Between Spyre Therapeutics and 743315AP8

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and 743315AP8 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and 743315AP8 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and PROGRESSIVE P OH, you can compare the effects of market volatilities on Spyre Therapeutics and 743315AP8 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of 743315AP8. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and 743315AP8.

Diversification Opportunities for Spyre Therapeutics and 743315AP8

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Spyre and 743315AP8 is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and PROGRESSIVE P OH in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PROGRESSIVE P OH and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with 743315AP8. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PROGRESSIVE P OH has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and 743315AP8 go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and 743315AP8

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the 743315AP8. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 1.07 times less risky than 743315AP8. The stock trades about -0.43 of its potential returns per unit of risk. The PROGRESSIVE P OH is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  8,119  in PROGRESSIVE P OH on September 12, 2024 and sell it today you would lose (64.00) from holding PROGRESSIVE P OH or give up 0.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy45.45%
ValuesDaily Returns

Spyre Therapeutics  vs.  PROGRESSIVE P OH

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
PROGRESSIVE P OH 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PROGRESSIVE P OH has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for PROGRESSIVE P OH investors.

Spyre Therapeutics and 743315AP8 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and 743315AP8

The main advantage of trading using opposite Spyre Therapeutics and 743315AP8 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, 743315AP8 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 743315AP8 will offset losses from the drop in 743315AP8's long position.
The idea behind Spyre Therapeutics and PROGRESSIVE P OH pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like